Teleflex Inc
TFX122.240USD
-0.050-0.04%
終値 12/24, 16:00（ET）15分遅れの株価
5.40B時価総額
損失額直近12ヶ月PER
詳細情報 Teleflex Inc 企業名
Teleflex Incorporated is a global provider of medical technologies. The Company offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
Teleflex Incの企業情報
企業コードTFX
会社名Teleflex Inc
上場日Mar 17, 1980
最高経営責任者「CEO」Kelly (Liam J)
従業員数14100
証券種類Ordinary Share
決算期末Mar 17
本社所在地550 E Swedesford Rd
都市WAYNE
証券取引所NASDAQ OMX NASDAQ Basic NYSE
国United States of America
郵便番号19087
電話番号16102256800
ウェブサイトhttps://www.teleflex.com/usa/en/#
企業コードTFX
上場日Mar 17, 1980
最高経営責任者「CEO」Kelly (Liam J)
Teleflex Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
50.99K
+3.03%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+12.60%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
10.22K
+10.84%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+15.59%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
6.54K
+18.04%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.66K
+9.70%
Mr. John C. Heinmiller
Mr. John C. Heinmiller
Independent Director
Independent Director
4.39K
+31.47%
Dr. Jaewon Ryu, M.D., J.D.
Dr. Jaewon Ryu, M.D., J.D.
Independent Director
Independent Director
3.08K
+95.06%
Ms. Neena M. Patil, J.D.
Ms. Neena M. Patil, J.D.
Independent Director
Independent Director
1.98K
+113.50%
Mr. John R. Deren
Mr. John R. Deren
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Liam J. Kelly
Mr. Liam J. Kelly
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
50.99K
+3.03%
Mr. Cameron P. Hicks
Mr. Cameron P. Hicks
Corporate Vice President - Human Resources and Communications
Corporate Vice President - Human Resources and Communications
10.38K
+12.60%
Mr. Stuart Allen (Stu) Randle
Mr. Stuart Allen (Stu) Randle
Independent Director
Independent Director
10.22K
+10.84%
Dr. Stephen K. Klasko, M.D.
Dr. Stephen K. Klasko, M.D.
Lead Independent Director
Lead Independent Director
10.06K
+15.59%
Mr. Andrew A. (Andy) Krakauer
Mr. Andrew A. (Andy) Krakauer
Independent Director
Independent Director
6.54K
+18.04%
Ms. Gretchen R. Haggerty
Ms. Gretchen R. Haggerty
Independent Director
Independent Director
5.66K
+9.70%
収益内訳
通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Vascular access
185.53M
23.76%
Interventional
170.02M
21.77%
Surgical
114.04M
14.60%
Anesthesia
96.39M
12.34%
OEM
78.67M
10.08%
他の
136.24M
17.45%
地域別USD
会社名
収益
比率
Americas
525.64M
67.31%
EMEA
166.23M
21.29%
Asia Pacific
89.03M
11.40%
事業別
地域別
事業別USD
会社名
収益
比率
Vascular access
185.53M
23.76%
Interventional
170.02M
21.77%
Surgical
114.04M
14.60%
Anesthesia
96.39M
12.34%
OEM
78.67M
10.08%
他の
136.24M
17.45%
株主
更新時刻: Mon, Nov 17
更新時刻: Mon, Nov 17
株主統計
種類
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
11.05%
The Vanguard Group, Inc.
10.81%
T. Rowe Price Investment Management, Inc.
10.34%
Janus Henderson Investors
9.42%
AQR Capital Management, LLC
5.35%
他の
53.03%
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
11.05%
The Vanguard Group, Inc.
10.81%
T. Rowe Price Investment Management, Inc.
10.34%
Janus Henderson Investors
9.42%
AQR Capital Management, LLC
5.35%
他の
53.03%
種類
株主統計
比率
Investment Advisor
57.71%
Investment Advisor/Hedge Fund
36.75%
Hedge Fund
9.11%
Pension Fund
1.76%
Sovereign Wealth Fund
1.36%
Research Firm
0.92%
Bank and Trust
0.57%
Family Office
0.37%
Individual Investor
0.34%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
1153
47.10M
106.58%
-5.30M
2025Q2
1158
48.67M
110.13%
-386.02K
2025Q1
1189
48.85M
110.52%
-721.30K
2024Q4
1180
47.47M
102.37%
-260.40K
2024Q3
1150
46.34M
98.36%
-1.83M
2024Q2
1147
46.98M
99.75%
-268.09K
2024Q1
1153
46.02M
97.70%
-1.89M
2023Q4
1170
46.05M
97.91%
-2.57M
2023Q3
1173
45.95M
97.77%
-3.19M
2023Q2
1201
46.87M
99.79%
-2.79M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
BlackRock Institutional Trust Company, N.A.
4.97M
11.25%
-385.28K
-7.19%
Jun 30, 2025
The Vanguard Group, Inc.
4.80M
10.86%
-269.49K
-5.32%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
5.94M
13.45%
-272.00K
-4.38%
Jun 30, 2025
Janus Henderson Investors
4.15M
9.39%
-176.31K
-4.08%
Jun 30, 2025
AQR Capital Management, LLC
409.32K
0.93%
+116.80K
+39.93%
Jun 30, 2025
Atlanta Capital Management Company, L.L.C.
2.40M
5.44%
-373.80K
-13.46%
Jun 30, 2025
State Street Investment Management (US)
1.46M
3.3%
-69.05K
-4.52%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.24M
2.81%
+373.94K
+43.09%
Jun 30, 2025
Cooke & Bieler, L.P.
1.21M
2.73%
+148.44K
+14.04%
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Invesco S&P SmallCap Health Care ETF
3.37%
First Trust Indxx Medical Devices ETF
2.09%
First Trust Health Care Alphadex Fund
1.77%
State Street SPDR S&P Health Care Equipment ETF
1.7%
Zacks Small/Mid Cap ETF
0.85%
State Street SPDR S&P 600 Small Cap Value ETF
0.75%
iShares S&P Small-Cap 600 Value ETF
0.75%
Distillate Small/Mid Cash Flow ETF
0.7%
VictoryShares Small Cap Free Cash Flow ETF
0.68%
iShares MSCI USA Small-Cap Min Vol Factor ETF
0.67%
詳細を見る
Invesco S&P SmallCap Health Care ETF
比率3.37%
First Trust Indxx Medical Devices ETF
比率2.09%
First Trust Health Care Alphadex Fund
比率1.77%
State Street SPDR S&P Health Care Equipment ETF
比率1.7%
Zacks Small/Mid Cap ETF
比率0.85%
State Street SPDR S&P 600 Small Cap Value ETF
比率0.75%
iShares S&P Small-Cap 600 Value ETF
比率0.75%
Distillate Small/Mid Cash Flow ETF
比率0.7%
VictoryShares Small Cap Free Cash Flow ETF
比率0.68%
iShares MSCI USA Small-Cap Min Vol Factor ETF
比率0.67%
配当金
過去5年間の配当金総支払額は
318.10M
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Nov 06, 2025
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2025 going ex on Nov 14, 2025
Nov 14, 2025
Dec 15, 2025
Nov 14, 2025
Jul 31, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 15, 2025 going ex on Aug 15, 2025
Aug 15, 2025
Sep 15, 2025
Aug 15, 2025
May 12, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 16, 2025 going ex on May 20, 2025
May 20, 2025
Jun 16, 2025
May 20, 2025
Feb 27, 2025
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 17, 2025 going ex on Mar 07, 2025
Mar 07, 2025
Mar 17, 2025
Mar 07, 2025
Oct 31, 2024
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 16, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Dec 16, 2024
Nov 15, 2024
Aug 01, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 16, 2024 going ex on Aug 15, 2024
Aug 15, 2024
Sep 16, 2024
Aug 15, 2024
May 06, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Jun 14, 2024 going ex on May 14, 2024
May 15, 2024
Jun 14, 2024
May 14, 2024
Feb 22, 2024
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Mar 15, 2024 going ex on Feb 29, 2024
Mar 01, 2024
Mar 15, 2024
Feb 29, 2024
Nov 02, 2023
TFX.NB Final Cash Dividend of gross USD 0.34 paid on Dec 15, 2023 going ex on Nov 14, 2023
Nov 15, 2023
Dec 15, 2023
Nov 14, 2023
Aug 03, 2023
TFX.NB Interim Cash Dividend of gross USD 0.34 paid on Sep 15, 2023 going ex on Aug 14, 2023
Aug 15, 2023
Sep 15, 2023
Aug 14, 2023
詳細を見る
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
よくある質問
Teleflex Incの上位5名の株主は誰ですか？
Teleflex Incの上位5名の株主は以下のとおりです。
BlackRock Institutional Trust Company, N.A.は4.97M株を保有しており、これは全体の11.25%に相当します。
The Vanguard Group, Inc.は4.80M株を保有しており、これは全体の10.86%に相当します。
T. Rowe Price Investment Management, Inc.は5.94M株を保有しており、これは全体の13.45%に相当します。
Janus Henderson Investorsは4.15M株を保有しており、これは全体の9.39%に相当します。
AQR Capital Management, LLCは409.32K株を保有しており、これは全体の0.93%に相当します。
BlackRock Institutional Trust Company, N.A.は4.97M株を保有しており、これは全体の11.25%に相当します。
The Vanguard Group, Inc.は4.80M株を保有しており、これは全体の10.86%に相当します。
T. Rowe Price Investment Management, Inc.は5.94M株を保有しており、これは全体の13.45%に相当します。
Janus Henderson Investorsは4.15M株を保有しており、これは全体の9.39%に相当します。
AQR Capital Management, LLCは409.32K株を保有しており、これは全体の0.93%に相当します。
Teleflex Incの株主タイプ上位3種は何ですか？
Teleflex Incの株主タイプ上位3種は、
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
T. Rowe Price Investment Management, Inc.
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
T. Rowe Price Investment Management, Inc.
Teleflex Inc（TFX）の株式を保有している機関の数はいくつですか？
2025Q3時点で、Teleflex Incの株式を保有している機関は1153社あり、保有株式の総市場価値は約47.10Mで、全体の106.58%を占めています。2025Q2と比較して、機関の持ち株は-3.56%増加しています。
Teleflex Incの最大の収益源は何ですか？
FY2025Q2において、Vascular access部門がTeleflex Incにとって最大の収益を生み出しており、その金額は185.53Mで、全収益の23.76%を占めています。
